HCC studies show ctDNA methylation assays (e.g., HepaAiQ) and virus-host DNA hybrids enhance early detection, while combining ctDNA with AFP, AFP-L3 and PIVKA-II yields superior accuracy (201, 208). Here, AFP is linked to hepatocellular carcinoma.